Economics
Trump's Sanctions Are Proving a Bitter Pill for Iran's Sick
- Penalties have made global banks wary of business with Iran
- Some medicines in short supply as noose tightens, price rises
A man works at a drugstore at the Nikan hospital in Tehran on Sept. 11.
Photographer: Stringer/AFP via Getty ImagesThis article is for subscribers only.
Leila Koochaki’s health has become collateral damage as the U.S. extends its economic offensive against Iran.
The 47-year-old had to contact 15 pharmacies across Tehran before she finally secured the anti-fatigue medication she takes to cope with multiple sclerosis. “I found a small drugstore that could give me a little, just two strips of 10 tablets each,” Koochaki said. “I begged them to keep it for me until I got there.”